Terms: = Prostate cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
740 results:
1. Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT.
Rosar F; Burgard C; David S; Marlowe RJ; Bartholomä M; Maus S; Petto S; Khreish F; Schaefer-Schuler A; Ezziddin S
Sci Rep; 2024 May; 14(1):11271. PubMed ID: 38760451
[TBL] [Abstract] [Full Text] [Related]
2. Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN.
Ma KC; Mena E; Lindenberg L; Lay NS; Eclarinal P; Citrin DE; Pinto PA; Wood BJ; Dahut WL; Gulley JL; Madan RA; Choyke PL; Turkbey IB; Harmon SA
Oncotarget; 2024 May; 15():288-300. PubMed ID: 38712741
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of quantitative whole body PET parameters on [
Ayati N; McIntosh L; Buteau J; Alipour R; Pudis M; Daw N; Jackson P; Hofman MS
Cancer Imaging; 2024 May; 24(1):57. PubMed ID: 38711135
[TBL] [Abstract] [Full Text] [Related]
4. Development, synthesis and validation of improved c-Myc/max inhibitors.
Yıldırım S; Kocabaş F; Mermer A
J Cell Mol Med; 2024 Apr; 28(8):e18272. PubMed ID: 38568057
[TBL] [Abstract] [Full Text] [Related]
5. A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients.
Lilly MB; Wu C; Ke Y; Chen WP; Soloff AC; Armeson K; Yokoyama NN; Li X; Song L; Yuan Y; McLaren CE; Zi X
Clin Transl Med; 2024 Mar; 14(3):e1627. PubMed ID: 38515274
[TBL] [Abstract] [Full Text] [Related]
6. Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.
Büttner T; Gärtner F; Essler M; Weiten R; Kristiansen G; Ellinger J; Ritter M; Krausewitz P
Prostate; 2024 Jun; 84(8):772-779. PubMed ID: 38504659
[TBL] [Abstract] [Full Text] [Related]
7. Improved early continence following laparoscopic radical prostatectomy: the urethral hammock technique.
Ortner G; Honis HR; Böhm J; Konschake M; Tokas T; Nagele U
World J Urol; 2024 Mar; 42(1):168. PubMed ID: 38492077
[TBL] [Abstract] [Full Text] [Related]
8. Darolutamide does not interfere with OATP-mediated uptake of docetaxel.
Buck SAJ; Talebi Z; Drabison T; Jin Y; Gibson AA; Hu P; de Bruijn P; de Ridder CMA; Stuurman D; Hu S; van Weerden WM; Koolen SLW; de Wit R; Sparreboom A; Mathijssen RHJ; Eisenmann ED
Int J Cancer; 2024 Jul; 155(2):314-323. PubMed ID: 38491867
[TBL] [Abstract] [Full Text] [Related]
9. Open-top Bessel beam two-photon light sheet microscopy for three-dimensional pathology.
Park WY; Yun J; Shin J; Oh BH; Yoon G; Hong SM; Kim KH
Elife; 2024 Mar; 12():. PubMed ID: 38488831
[TBL] [Abstract] [Full Text] [Related]
10. Strong Correlation Between SUV
Berrens AC; Sorbi MA; Donswijk ML; de Barros HA; Azargoshasb S; van Oosterom MN; Rietbergen DDD; Bekers EM; van der Poel HG; van Leeuwen FWB; van Leeuwen PJ
J Nucl Med; 2024 Apr; 65(4):548-554. PubMed ID: 38485277
[TBL] [Abstract] [Full Text] [Related]
11. Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression.
Chen Z; Wang M; Wu D; Bai L; Xu T; Metwally H; Wang Y; McEachern D; Zhao L; Li R; Takyi-Williams J; Wang M; Wang L; Li Q; Wen B; Sun D; Wang S
J Med Chem; 2024 Apr; 67(7):5275-5304. PubMed ID: 38477974
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Performance of RECIP 1.0 Based on [
Hartrampf PE; Hüttmann T; Seitz AK; Kübler H; Serfling SE; Higuchi T; Schlötelburg W; Michalski K; Gafita A; Rowe SP; Pomper MG; Buck AK; Werner RA
J Nucl Med; 2024 Apr; 65(4):560-565. PubMed ID: 38453363
[TBL] [Abstract] [Full Text] [Related]
13. Demonstrating Bioequivalence for Two Dose Strengths of Niraparib and Abiraterone Acetate Dual-Action Tablets Versus Single Agents: Utility of Clinical Study Data Supplemented with Modeling and Simulation.
Yu A; Hazra A; Jiao JJ; Hellemans P; Mitselos A; Tian H; Ruixo JJP; Haddish-Berhane N; Ouellet D; Russu A
Clin Pharmacokinet; 2024 Apr; 63(4):511-527. PubMed ID: 38436924
[TBL] [Abstract] [Full Text] [Related]
14. Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.
Kamada S; Sakamoto S; Kinoshita R; Zhao X; Kamasako T; Yamase R; Junryo R; Saito S; Sangjon P; Takei A; Yamada Y; Goto Y; Imamura Y; Iguchi T; Mizokami A; Suzuki H; Akakura K; Ichikawa T
Prostate; 2024 May; 84(7):636-643. PubMed ID: 38413843
[TBL] [Abstract] [Full Text] [Related]
15. Bony lesion analysis in carcinoma prostate: methylene diphosphonate bone scan vs. Gallium-68 psma-11 pet/ct.
Ali H; Rashid Ul Amin S; Hai A; Nizar N
J Ayub Med Coll Abbottabad; 2023; 35(3):415-418. PubMed ID: 38404083
[TBL] [Abstract] [Full Text] [Related]
16. [
Rosar F; Burgard C; Larsen E; Khreish F; Marlowe RJ; Schaefer-Schuler A; Maus S; Petto S; Bartholomä M; Ezziddin S
Cancer Imaging; 2024 Feb; 24(1):27. PubMed ID: 38389092
[TBL] [Abstract] [Full Text] [Related]
17. The association between age and long-term quality of life after curative treatment for prostate cancer: a cross-sectional study.
Sletten R; Berger Christiansen O; Oldervoll LM; Åstrøm L; Kjesbu Skjellegrind H; Šaltytė Benth J; Kirkevold Ø; Bergh S; Grønberg BH; Rostoft S; Bye A; Mork PJ; Slaaen M
Scand J Urol; 2024 Feb; 59():31-38. PubMed ID: 38379397
[TBL] [Abstract] [Full Text] [Related]
18. Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan.
Akakura K; Uemura H; Kawakami S; Yokomizo A; Nakamura M; Nishimura K; Komori T; Ledesma DA
Future Oncol; 2024 Apr; 20(12):781-798. PubMed ID: 38275149
[TBL] [Abstract] [Full Text] [Related]
19. Incidental prostate-Specific Membrane Antigen-Avid Vestibular Schwannoma Detected on 68 Ga-prostate-Specific Membrane Antigen PET/CT.
Chen J; Bui P; Bui C; Mansberg R
Clin Nucl Med; 2024 Mar; 49(3):234-236. PubMed ID: 38271251
[TBL] [Abstract] [Full Text] [Related]
20. Patient reported outcomes of intermittent self-dilatation after direct vision internal urethrotomy.
Scheipner L; Jankovic D; Jasarevic S; Seidl M; Altziebler JV; Pemberger K; Pohl KC; Primus G; Tian Z; Leitsmann M; Ahyai S
Neurourol Urodyn; 2024 Mar; 43(3):664-671. PubMed ID: 38221870
[TBL] [Abstract] [Full Text] [Related]
[Next]
